Adagio Medical Holdings Statistics
Total Valuation
ADGM has a market cap or net worth of $57.03 million. The enterprise value is $194.64 million.
Important Dates
The last earnings date was Monday, August 26, 2024, before market open.
Earnings Date | Aug 26, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ADGM has 13.39 million shares outstanding.
Shares Outstanding | 13.39M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +2.98% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 12.06M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 12.78 |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 731.73 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.13
Current Ratio | 0.13 |
Quick Ratio | 0.07 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -13.81 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $3,129 |
Profits Per Employee | -$433,976 |
Employee Count | 85 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | -0.03 |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 33.76 |
Average Volume (20 Days) | 28,929 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ADGM had revenue of $266,000 and -$36.89 million in losses. Loss per share was -$48.19.
Revenue | 266,000 |
Gross Profit | -1.26M |
Operating Income | -30.10M |
Pretax Income | n/a |
Net Income | -36.89M |
EBITDA | -29.37M |
EBIT | -30.10M |
Loss Per Share | -$48.19 |
Full Income Statement Balance Sheet
The company has $4.08 million in cash and $47.81 million in debt, giving a net cash position of -$43.73 million or -$3.27 per share.
Cash & Cash Equivalents | 4.08M |
Total Debt | 47.81M |
Net Cash | -43.73M |
Net Cash Per Share | -$3.27 |
Equity (Book Value) | -50.01M |
Book Value Per Share | -181.37 |
Working Capital | -51.37M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$25.99 million and capital expenditures -$435,000, giving a free cash flow of -$26.43 million.
Operating Cash Flow | -25.99M |
Capital Expenditures | -435,000 |
Free Cash Flow | -26.43M |
FCF Per Share | -$1.97 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -11,316.92% |
Pretax Margin | -13,867.67% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |